Leukocyte response to thymoglobulin or Atgam for induction immunosuppression in a randomized, double-blind clinical trial in renal transplant recipients

Transplantation Proceedings

Volumn 31, Issue 3 SUPPL. 2, 1999, Pages 16S-18S

  Brennan, D C ^a   Flavin, K ^a   Lowell, J A ^a   Howard, T K ^a   Shenoy, S ^a   Burgess, S ^a   Dolan, S ^a   Kano, J M ^c   Mahon, M ^a   Schnitzler, M A ^a,b   Woodward, R ^a,b   Irish, W ^c   Ramachamdra, V ^a   Singer, G G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

^c GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; METHYLPREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY;

BACTERIAL INFECTION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MYCOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0032941392     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(99)00096-2     Document Type: Conference Paper

References (5)

1. Cecka J.M., Cho Y.W., Terasaki P.I. Transplantation. 53:1992;59.
2. Norman D.J., Kahana L., Stuart F.P. Jr, et al. Transplantation. 55:1993;44.
3. Hibberd P.L., Tolkoff-Rubin N.E., Cosimi A.B., et al. Transplantation. 53:1992;68.
4. Swinnen L.J., Costanzo-Nordin M.R., Fisher S.G., et al. N Engl J Med. 323:1990;1723.
5. Gaber A.O., First M.R., Tesi R.J., et al. Transplantation. 66:1998;29.